Gabriele Romano

This study shows that blocking PSGL-1 with BRAF/MEK inhibition improves durable tumor control in melanoma by reprogramming CD8+ T cells to a memory-like state.

This study shows that disabling PSGL-1 enhances anti-tumor immunity in pancreatic cancer by improving CD8+ T cell function and response to PD-1 blockade.

This paper analyzes melanoma in people living with HIV, finding impaired antitumor immunity, delayed ICI treatment, and an immunosuppressive tumor microenvironment.